#FDA

Lead report

In-Depth Analysis: Is the Nasdaq Biotech Surge the Next Big Trend or a Fleeting Phenomenon?

This article analyzes why the Nasdaq Biotech Index is outperforming the broader market, examining factors from FDA policy and M&A trends to technological breakthroughs and capital flows to determine if this is a sustainable opportunity or a short-term event.